Immune Checkpoint Inhibitor Therapy Achieved Complete Response for Drug-Sensitive EGFR/ALK Mutation-Negative Metastatic Pulmonary Large-Cell Neuroendocrine Carcinoma with High Tumor Mutation Burden: A Case Report

Large-cell neuroendocrine lung carcinoma (LCNELC) is classified into lung neuroendocrine tumors according to WHO 2015 classification guidelines and represents approximately 3% of all lung cancer. Because of the rarity of LCNELC, there is a lack of prospective studies guiding treatment. Here, we repo...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xin, Sun, Yanbin, Miao, Yuan, Xu, Shun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443410/
https://www.ncbi.nlm.nih.gov/pubmed/32884302
http://dx.doi.org/10.2147/OTT.S259893

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443410/
https://www.ncbi.nlm.nih.gov/pubmed/32884302
http://dx.doi.org/10.2147/OTT.S259893

Ejemplares similares